Senior finance executive and investor focused on emerging markets, Steven JE Manders brings operational and capital-markets experience spanning corporate finance, strategic advisory and private investments. Known for structuring cross-border transactions and portfolio optimization, he has worked with corporates and PE firms on M&A, capital raising and turnaround assignments. Market-oriented analyst with emphasis on governance, cash-flow improvement and value realization; active in board advisory and deal sourcing across fintech, energy and industrial sectors.
Senior finance executive and investor focused on emerging markets, Steven JE Manders brings operational and capital-markets experience spanning corporate finance, strategic advisory and private investments. Known for structuring cross-border transactions and portfolio optimization, he has worked with corporates and PE firms on M&A, capital raising and turnaround assignments. Market-oriented analyst with emphasis on governance, cash-flow improvement and value realization; active in board advisory and deal sourcing across fintech, energy and industrial sectors.
Seasoned emerging-markets investor who prioritizes cash-flow-driven value and disciplined capital allocation. Focuses on control and minority investments that enable operational turnaround, governance upgrades and cross-border structuring to unlock value. Balances private equity-style active ownership with strategic advisory, favoring fintech, energy and industrials where structural growth and margin improvement are visible. Uses rigorous underwriting, scenario-based stress tests and staged capital release to manage downside while targeting multi-year capital appreciation through portfolio optimization and exit planning.
Seasoned emerging-markets investor who prioritizes cash-flow-driven value and disciplined capital allocation. Focuses on control and minority investments that enable operational turnaround, governance upgrades and cross-border structuring to unlock value. Balances private equity-style active ownership with strategic advisory, favoring fintech, energy and industrials where structural growth and margin improvement are visible. Uses rigorous underwriting, scenario-based stress tests and staged capital release to manage downside while targeting multi-year capital appreciation through portfolio optimization and exit planning.
| Trades 2060 | Longs Won 1552/2060 75% | Profit Factor 21.94 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.71M |
| Average Win $135,486.23 | Best Trade (Mar 30) $72.22M | Sharpe Ratio -10.03 |
| Average Loss -$18,866.75 | Worst Trade (Sep 29) -$592,661.96 | Z-Score 17.09 (100%) |
| Commissions $0 | Avg. Trade Length 1y 1w 5d | Expectancy $97,422.49 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.01% | 0.11% | 1.4% | 13.32% |
| Consecutive Losing Trades | 15,385 | 13,846 | 12,308 | 10,769 | 9,231 | 7,692 | 6,154 | 4,615 | 3,077 | 1,538 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 45,360 | $10.02M | $14.01M | - | $3.99M | 39.82% | -7.354% |
ABBV AbbVie Inc. | 1,180 | $226,973.45 | $296,109.2 | - | $69,135.75 | 30.46% | -2.513% |
ABT Abbott Laboratories | 5,935 | $737,374.12 | $627,329.5 | - | -$110,044.62 | -14.92% | +0.085% |
ADI Analog Devices, Inc. | 12,810 | $2.8M | $4.71M | - | $1.91M | 68.05% | +0.202% |
AEP American Electric Power Company, Inc. | 5,229 | $536,268.26 | $668,527.65 | - | $132,259.39 | 24.66% | +0.055% |
AFL Aflac Inc. | 1,767 | $196,473.39 | $225,257.16 | - | $28,783.77 | 14.65% | +0.094% |
AGG iShares Core U.S. Aggregate Bond ETF | 6,618 | $647,564.11 | $644,394.66 | - | -$3,169.45 | -0.49% | -0.256% |
AMAT Applied Materials, Inc. | 400 | $289,200 | $203,068 | - | -$86,132 | -29.78% | +1.176% |
AMD Advanced Micro Devices, Inc. | 364 | $211,451 | $173,318.6 | - | -$38,132.4 | -18.03% | -1.904% |
AMGN Amgen Inc. | 5,715 | $1.65M | $2.2M | - | $552,138.05 | 33.48% | -0.64% |
AMZN Amazon.com Inc | 7,234 | $1.64M | $1.96M | - | $320,768.79 | 19.51% | +15.321% |
ARCC Ares Capital Corporation | 56,152 | $1.12M | $1.05M | - | -$63,117.68 | -5.65% | -0.372% |
ASML ASML Holding N.V. New York Registry Shares | 1,102 | $845,548.31 | $1.8M | - | $949,609.69 | 112.31% | -1.359% |
AVGO Broadcom Inc. | 19,317 | $4.12M | $7.52M | - | $3.4M | 82.49% | +0.371% |
AZN AstraZeneca PLC American Depositary Shares | 3,070 | $603,144.08 | $520,794.8 | - | -$82,349.28 | -13.65% | -0.992% |
BAC Bank of America Corporation | 5,054 | $225,302.21 | $313,095.3 | - | $87,793.09 | 38.97% | +0.356% |
BAR GraniteShares Gold Trust | 34,540 | $961,780.56 | $1.38M | - | $414,638.44 | 43.11% | -1.508% |
BCS Barclays PLC Sponsored ADR | 34,269 | $721,816.12 | $942,397.5 | - | $220,581.38 | 30.56% | -0.722% |
BLK BlackRock, Inc. | 3,706 | $3.82M | $4.04M | - | $225,528.63 | 5.91% | -0.727% |
BNY BlackRock New York Municipal Income Trust | 1,809 | $197,997.8 | $282,800.97 | - | $84,803.17 | 42.83% | +0.16% |